Lucio A.A. Van Rooijen

Author

Also Known As

L. A. A. van Rooijen, L.A.A. van Rooijen, LUCIO A. A. VAN ROOIJEN, Lucio A. A. Van Rooijen, Lucio A. A. van Rooijen, Lucio A.A. Van Rooijen, Lucio A.A. van Rooijen

Publications

468

Citations

H-Index

Concepts

All Affiliations

University of Michigan Stadtwerke Köln (Germany)Louisiana State University University of Cologne University Medical Center New Orleans

About

Lucio A.A. Van Rooijen is an author at University of Michigan specializing in medicine, pharmacology, and molecular pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	295
2	Natural Sciences	3	3	76
3	Social Sciences	2	2	40
4	Engineering	1	1	79
5	Allergy	1	1	32

Lucio A.A. Van Rooijen

Publications

421

Citations

H-Index

Page 1

	Year	Citations
Renewed interest in the polyphosphoinositides Stephen K. Fisher, Lucio A.A. Van Rooijen, Bernard W. Agranoff Trends in Biochemical Sciences EngineeringProtein PhosphorylationPeptide SciencePhosphorenePolymer Chemistry	1984	79
Phosphodiesteratic breakdown of endogenous polyphosphoinositides in nerve ending membranes Lucio A.A. Van Rooijen, Edward B. Seguin, Bernard W. Agranoff Biochemical and Biophysical Research Communications Membrane TransportPhysiologyElectrophysiologyPhosphodiesteratic BreakdownMembrane Permeation	1983	59
Inhibition of phosphatidylinositol-4-phosphate kinase by its product phosphatidylinositol-4,5-bisphosphate Lucio A.A. Van Rooijen, Magdalena J. Rossowska, Nicolás G. Bazán Biochemical and Biophysical Research Communications Signal TransductionSignaling PathwayBiochemistryMedicineNatural Sciences	1985	54
Inhibition of polyphosphoinositide phosphodiesterase by aminoglycoside antibiotics Lucio A.A. Van Rooijen, Bernard W. Agranoff Neurochemical Research Medicinal ChemistryAntibioticsMedicinePharmacotherapyAntimicrobial Chemotherapy	1985	36
Polymyxin B is a selective and potent antagonist of calmodulin L. Hegemann, Lucio A.A. Van Rooijen, J. Traber, European Journal of Pharmacology Molecular Pharmacology Molecular PharmacologyAllergyMedicineMechanism Of ActionNeuropharmacology	1991	32
Enhanced inositide turnover in brain during bicuculline-induced status epilepticus Lucio A.A. Van Rooijen, Robert Vadnal, Paul Dobard, Biochemical and Biophysical Research Communications Enhanced Inositide TurnoverNeurophysiologyNeuropharmacologyNeurologyNeurotransmission	1986	28
Induction of rat hepatic ornithine decarboxylase by the tumor promotors 12-O-tetradecanoylphorbol-13-acetate and phenobarbital in vivo; effect of retinyl-acetate A. Bisschop, Lucio A.A. Van Rooijen, H.J.G.M. Derks, Carcinogenesis	1981	24
Tetraenoic Species Are Conserved in Muscarinically Enhanced Inositide Turnover Lucio A.A. Van Rooijen, Amiya K. Hajra, Bernard W. Agranoff Journal of Neurochemistry	1985	23
The antipsoriatic drug, anthralin, inhibits protein kinase C — implications for its mechanism of action L. Hegemann, R. Fruchtmann, Lucio A.A. Van Rooijen, Archives of Dermatological Research Molecular PharmacologySignal TransductionMedicineReceptor Tyrosine KinaseImmunology	1992	22
Effects of tiflucarbine as a dual protein kinase C/calmodulin antagonist on proliferation of human keratinocytes and release of reactive oxygen species from human leukocytes L. Hegemann, R. Fruchtmann, Bernd Bonnekoh, Archives of Dermatological Research InflammationAnti-inflammatoryMedicineHuman LeukocytesImmunology	1991	15

Page 1